2026 Jeffrey D. Esko: Biology and Biochemistry Researcher – H-Index, Publications & Awards

D-Index & Metrics

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	109	988	874	604	522	493	56417

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Biology and Biochemistry

109

988

874

604

522

493

56417

Biology and Biochemistry

D-Index

109

Citations

56417

World Ranking

988

National Ranking

604

Research.com Recognitions

2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Jeffrey D. Esko is affiliated with the University of California, San Diego in the United States. Their research spans significant areas in biochemistry, genetics, molecular biology, and medicine, focusing on the molecular and cellular mechanisms underlying health and disease.

Their recent publication record includes a focus on viral infections and cellular interactions, particularly relating to SARS-CoV-2. Some notable papers are:

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 (2020, Cell)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 (2020, bioRxiv - Cold Spring Harbor Laboratory)
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 (2021, Nature)
Spike-heparan sulfate interactions in SARS-CoV-2 infection (2022, Current Opinion in Structural Biology)
Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote skeletal muscle proteolysis (2022, Nature Cell Biology)

The scientist's work engages multiple topics, including:

Proteoglycans and glycosaminoglycans research
Glycosylation and glycoproteins research
COVID-19 clinical research studies
SARS-CoV-2 and COVID-19 research
Fibroblast growth factor research
Cell adhesion molecules research
Lysosomal storage disorders research

Their main fields of study consist of:

Biochemistry, Genetics and Molecular Biology
Medicine

Within these broader fields, subfields include:

Molecular Biology
Cell Biology
Infectious Diseases
Epidemiology
Immunology

Frequent publication venues where this scientist has contributed extensively include:

bioRxiv (Cold Spring Harbor Laboratory)
The FASEB Journal
Nature Communications
Journal of Biological Chemistry
Glycobiology

Among collaborators frequently working with this scientist are:

Thomas Mandel Clausen
Alejandro Gómez Toledo
Philip L.S.M. Gordts
Daniel R. Sandoval
Nathan E. Lewis

Jeffrey D. Esko was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2012.

Best Publications

Essentials of Glycobiology [Internet]

Ajit Varki;Richard D Cummings;Jeffrey D Esko;Pamela Stanley

5477
Citations
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Avner Yayon;Michael Klagsbrun;Jeffrey D. Esko;Philip Leder

3072
Citations
Essentials of Glycobiology

Ajit Varki;Richard D Cummings;Jeffrey D Esko;Hudson H Freeze

2719
Citations
Heparan sulphate proteoglycans fine-tune mammalian physiology

Joseph R. Bishop;Manuela Schuksz;Jeffrey D. Esko

1877
Citations
Order out of chaos: assembly of ligand binding sites in heparan sulfate.

Jeffrey D. Esko;Scott B. Selleck

1781
Citations
Heparan Sulfate Proteoglycans

Stephane Sarrazin;William C. Lamanna;Jeffrey D. Esko

1741
Citations
The sweet and sour of cancer: glycans as novel therapeutic targets.

Mark M. Fuster;Jeffrey D. Esko

1586
Citations
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

Yaping Chen;Terry Maguire;Ronald E. Hileman;Jonathan R. Fromm

1360
Citations
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

Deepak Shukla;Jian Liu;Peter Blaiklock;Nicholas W. Shworak;Nicholas W. Shworak

1279
Citations
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.

Thomas Mandel Clausen;Thomas Mandel Clausen;Thomas Mandel Clausen;Daniel R. Sandoval;Charlotte B. Spliid;Charlotte B. Spliid;Charlotte B. Spliid;Jessica Pihl;Jessica Pihl;Jessica Pihl

1162
Citations
Molecular diversity of heparan sulfate

Jeffrey D. Esko;Ulf Lindahl

1120
Citations
Symbol Nomenclature for Graphical Representations of Glycans.

Ajit Varki;Richard D. Cummings;Markus Aebi;Nicole H. Packer

1070
Citations
Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans.

Mei-Tsu Shieh;D. Wudunn;R. I. Montgomery;J. D. Esko

781
Citations
Demystifying Heparan Sulfate–Protein Interactions

Ding Xu;Jeffrey D Esko

763
Citations
Animal cell mutants defective in glycosaminoglycan biosynthesis

Jeffrey D. Esko;Tod E. Stewart;William H. Taylor

731
Citations
Loss of HIF-1α in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis

Nan Tang;Lianchun Wang;Jeffrey Esko;Frank J. Giordano

655
Citations
Proteoglycans and Sulfated Glycosaminoglycans

Jeffrey D Esko;Koji Kimata;Ulf Lindahl

598
Citations
Microbial adherence to and invasion through proteoglycans.

K S Rostand;J D Esko

597
Citations
Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses.

Lianchun Wang;Mark Fuster;P Sriramarao;Jeffrey D Esko

579
Citations
Disruption of Gastrulation and Heparan Sulfate Biosynthesis in EXT1-Deficient Mice

Xin Lin;Ge Wei;Zhengzheng Shi;Laurence Dryer

526
Citations